Skip to content

Characterization of Bilateral Vestibulopathy II

Characterization of Bilateral Vestibulopathy II - Characterization of Bilateral Vestibulopathy II

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON49984
Enrollment
60
Registered
2020-04-29
Start date
2021-08-23
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total loss of balance function

Interventions

None listed

Sponsors

Medisch Universitair Ziekenhuis Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: - Bilateral vestibulopathy, diagnosed at Maastricht University Medical Center according to the Bárány criteria: * Horizontal angular VOR gain bilaterally 68 degrees on torsion swing test) - >18 years old - Giving informed consent

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: - Not being able (e.g. mentally disabled) or willing to talk about one of the investigated issues (e.g. psychology/psychiatry, health care utilization - Not being able or willing to undergo one of the detailed physical, audiometric or vestibular examinations. - Not being able to stop medication against anxiety or depression (after consulting their general practitioner) - Not wanting to be informed about any incidental findings

Design outcomes

Primary

MeasureTime frame
1. A defined diagnostic approach for patients with bilateral vestibulopathy. 2. Defined strict inclusion criteria for vestibular implantation 3. A detailed insight in the patient expectations of the vestibular implant 4. A detailed insight into consumption of health care by patients with bilateral vestibulopathy

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)